AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

MEDICAL DEVELOPMENTS INTERNA

0.495

-0.005-1.00%

Volume:11.18K

Turnover:5K

Market Cap:55.77M

PE:93.40

High:0.495

Open:0.485

Low:0.485

Close:0.500

52wk High:0.765

52wk Low:0.365

Shares:112.66M

Float Shares:81.69M

Volume Ratio:0.09

T/O Rate:0.01%

Dividend:- -

Dividend Rate:- -

EPS(TTM):0.005

EPS(LYR):0.005

ROE:1.13%

ROA:2.28%

PB:1.00

PE(LYR):93.40

Loading ...

Overview Company News Filings

Concept

Pharmaceutical Companies-0.31%

Capital Flow

Inflow:

Outflow:

News

King River Resources And 2 Other ASX Penny Stocks To Consider

Simply Wall St.

Medical Developments International Logs FY Full Revenue A$42.6 Million

Medical Developments International - FY26 EBIT is NOW Expected to be Modestly Improved on FY25

THOMSON REUTERS

Medical Developments International - FY26 Full Year Revenue was A$42.6 Mln, up A$3.5 Mln Versus Prior Period

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigerfiesta.com/stock/MVP.AU"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"MVP.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"MVP.AU\",,,,,undefined,":{"symbol":"MVP.AU","market":"AU","secType":"STK","nameCN":"MEDICAL DEVELOPMENTS INTERNA","latestPrice":0.495,"timestamp":1789539120000,"preClose":0.5,"halted":0,"volume":11175,"delay":0,"changeRate":-0.010000000000000009,"nameEN":"MEDICAL DEVELOPMENTS INTERNA","floatShares":81690477,"shares":112658324,"eps":0.0053,"marketStatus":"Not Yet Opened","change":-0.005,"latestTime":"09-16 16:12:00 AEST","open":0.485,"high":0.495,"low":0.485,"amount":5447,"amplitude":0.02,"askPrice":0.495,"askSize":1267,"bidPrice":0.48,"bidSize":60334,"shortable":3,"etf":0,"ttmEps":0.0053,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1789603200000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":0.5,"openAndCloseTimeList":[[1789516800000,1789538400000]],"volumeRatio":0.085708,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"MVP.AU","preClose":0.5,"auctionPrice":0.5,"auctionVolume":42839,"auction":3,"marketStatus":"盘后竞价","timestamp":1789452600500}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"MVP.AU\",,,,,undefined,":{"symbol":"MVP.AU","floatShares":81690477,"roa":"2.28%","roe":"1.13%","lyrEps":0.0053,"volumeRatio":0.085708,"shares":112658324,"dividePrice":0,"high":0.495,"amplitude":0.02,"preClose":0.5,"low":0.485,"week52Low":0.365,"pbRate":"1.00","psRate":"1.31","week52High":0.765,"institutionHeld":0,"latestPrice":0.495,"committee":0.958864,"eps":0.0053,"divideRate":0,"volume":11175,"delay":0,"ttmEps":0.0053,"open":0.485,"prevYearClose":0.555,"prevWeekClose":0.5,"prevMonthClose":0.46,"prevQuarterClose":0.395,"fiveDayClose":0.52,"twentyDayClose":0.515,"sixtyDayClose":0.41,"dividendPayoutRate":6.922810661128418,"dividendGrowthYears":1,"dividendGrowthRate":1,"fiveYearAvgDividendRate":0.004752121965724171},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MVP.AU\",params:#limit:5,,,undefined,":[{"date":"2026-08-20","symbol":"MVP.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787184000000,"name":null,"time":"","dateTimestamp":1787148000000,"actualEps":null},{"date":"2026-02-19","symbol":"MVP.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1771455600000,"name":null,"time":"","dateTimestamp":1771419600000,"actualEps":null},{"date":"2025-08-21","symbol":"MVP.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1755734400000,"name":null,"time":"","dateTimestamp":1755698400000,"actualEps":null},{"date":"2025-02-20","symbol":"MVP.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1740006000000,"name":null,"time":"","dateTimestamp":1739970000000,"actualEps":null},{"date":"2024-08-26","symbol":"MVP.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724630400000,"name":null,"time":"","dateTimestamp":1724594400000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MVP.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MVP.AU\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2654067911","title":"King River Resources And 2 Other ASX Penny Stocks To Consider","url":"https://stock-news.laohu8.com/highlight/detail?id=2654067911","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654067911?lang=en_us&edition=fundamental","pubTime":"2026-07-27 03:01","pubTimestamp":1785092519,"startTime":"0","endTime":"0","summary":"The Australian stock market is experiencing a slight downturn, influenced by renewed U.S.-Iran tensions and rising oil prices. In such fluctuating conditions, investors often turn to penny stocks—companies that may be smaller or less established but can offer significant value when backed by solid financials. Despite the term's old-fashioned ring, these stocks remain relevant for those seeking opportunities in under-the-radar companies with potential for growth and stability.","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/2052000-choice2-main-header/1585186553865","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/2052000-choice2-main-header/1585186553865"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/materials/asx-krr/king-river-resources-shares/news/king-river-resources-and-2-other-asx-penny-stocks-to-conside","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/materials/asx-krr/king-river-resources-shares/news/king-river-resources-and-2-other-asx-penny-stocks-to-conside","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["MVP.AU","BK7508","BK7095","BK7096","TVN.AU","KRR.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653770320","title":"Medical Developments International Logs FY Full Revenue A$42.6 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2653770320","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653770320?lang=en_us&edition=fundamental","pubTime":"2026-07-24 09:34","pubTimestamp":1784856875,"startTime":"0","endTime":"0","summary":"BRIEF-Medical Developments International Logs FY Full Revenue A$42.6 MillionJuly 24 -Medical Developments International LtdMVP.AX:FY26 FULL YEAR REVENUE WAS A$42.6 MILLION, UP A$3.5 MILLION VERSUS PRIOR PERIODFY26 EBIT IS NOW EXPECTED TO BE MODESTLY IMPROVED ON FY25Further company coverage:MVP.AX","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260724:nFWN43P1EH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","BK7096","MVP.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653771134","title":"Medical Developments International - FY26 EBIT is NOW Expected to be Modestly Improved on FY25","url":"https://stock-news.laohu8.com/highlight/detail?id=2653771134","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653771134?lang=en_us&edition=fundamental","pubTime":"2026-07-24 06:24","pubTimestamp":1784845491,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260723:nFWN43P1EH:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","MVP.AU","BK7096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653771132","title":"Medical Developments International - FY26 Full Year Revenue was A$42.6 Mln, up A$3.5 Mln Versus Prior Period","url":"https://stock-news.laohu8.com/highlight/detail?id=2653771132","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653771132?lang=en_us&edition=fundamental","pubTime":"2026-07-24 06:24","pubTimestamp":1784845491,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260723:nFWN43P1EH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","MVP.AU","BK7096"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":3,"pageCount":1,"totalSize":9,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/MVP.AU\",params:#limit:6,delay:true,,,undefined,":[{"market":"AU","name":"Pharmaceutical Companies","id":"package_au_concept_yyswg","bkCode":"BK7508","changeRate":-0.003125}]}}